{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T19:10:02Z","timestamp":1719947402030},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s11940-003-0008-x","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T19:07:37Z","timestamp":1180984057000},"page":"177-185","source":"Crossref","is-referenced-by-count":3,"title":["Gait and balance dysfunction in adults"],"prefix":"10.1007","volume":"5","author":[{"given":"Salil","family":"Manek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark F.","family":"Lew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"8_CR1","first-page":"111","volume":"87","author":"L Sudarsky","year":"2001","unstructured":"Sudarsky L: Gait disorders: prevalence, morbidity, and etiology. Adv Neurol 2001, 87:111\u2013117.","journal-title":"Adv Neurol"},{"key":"8_CR2","first-page":"347","volume":"87","author":"ME Morris","year":"2001","unstructured":"Morris ME, Huxman FE, McGinley J, Iansek R: Gait disorders and gait rehabilitation in Parkinson\u2019s disease. Adv Neurol 2001, 87:347\u2013361. Describes the improvement in gait parameters with rehabilitation of Parkinson\u2019s disease.","journal-title":"Adv Neurol"},{"key":"8_CR3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0749-0690(18)30203-9","volume":"12","author":"MW Rogers","year":"1996","unstructured":"Rogers MW: Disorders of posture, balance, and gait in Parkinson\u2019s disease. Clin Ger Med 1996, 12:825\u2013845.","journal-title":"Clin Ger Med"},{"key":"8_CR4","first-page":"119","volume":"87","author":"J Jankovic","year":"2001","unstructured":"Jankovic J, Nutt JG, Sudarsky L: Classification, diagnosis, and etiology of gait disorders. Adv Neurol 2001, 87:119\u2013133. A concise summary of classification and etiology of gait disorders.","journal-title":"Adv Neurol"},{"key":"8_CR5","first-page":"199","volume":"87","author":"N Yanagisawa","year":"2001","unstructured":"Yanagisawa N, Hayashi R, Mitoma H: Pathophysiology of frozen gait in Parkinsonism. Adv Neurol 2001, 87:199\u2013207.","journal-title":"Adv Neurol"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jnnp.70.3.289","volume":"70","author":"H Stolze","year":"2001","unstructured":"Stolze H, Kuhtz-Buschbeck JP, Drucke H, et al.: Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 2001, 70:289\u2013297.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8_CR7","first-page":"135","volume":"87","author":"JG Nutt","year":"2001","unstructured":"Nutt JG: Classification of gait and balance disorders. Adv Neurol 2001, 87:135\u2013141.","journal-title":"Adv Neurol"},{"key":"8_CR8","first-page":"301","volume":"87","author":"JK Krauss","year":"2001","unstructured":"Krauss JK, Faist M, Schubert M, et al.: Evaluation of gait in normal pressure hydrocephalus before and after shunting. Adv Neurol 2001, 87:301\u2013310.","journal-title":"Adv Neurol"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1042-3680(18)30033-0","volume":"36","author":"CA Hakim","year":"2001","unstructured":"Hakim CA, Hakim R, Hakim S: Normal pressure hydrocephalus. Neurosurg Clin North Am 2001, 36:761\u2013773.","journal-title":"Neurosurg Clin North Am"},{"key":"8_CR10","first-page":"1665","volume":"22","author":"M Tullberg","year":"2001","unstructured":"Tullberg M, Jensen C, Ekholm S, Wikkelso C: Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery. AJNR 2001, 22:1665\u20131673.","journal-title":"AJNR"},{"key":"8_CR11","first-page":"1638","volume":"22","author":"WG Bradley","year":"2001","unstructured":"Bradley WG: Normal pressure hydrocephalus and deep white matter ischemia: which is the chicken and which is the egg? AJNR 2001, 22:1638\u20131640.","journal-title":"AJNR"},{"key":"8_CR12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1034\/j.1600-0404.2001.00092.x","volume":"104","author":"BK Owler","year":"2001","unstructured":"Owler BK, Pickard JD: Normal pressure hydrocephalus and cerebral blood flow: a review. Acta Neurol Scand 2001, 104:325\u2013342.","journal-title":"Acta Neurol Scand"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00019052-199912000-00002","volume":"12","author":"RG Corkill","year":"1999","unstructured":"Corkill RG, Cadoux-Hudson TAD: Normal pressure hydrocephalus: developments in determining surgical prognosis. Curr Opin Neurol 1999, 12:671\u2013677.","journal-title":"Curr Opin Neurol"},{"key":"8_CR14","first-page":"503","volume":"72","author":"R Walchenbach","year":"2002","unstructured":"Walchenbach R, Geiger E, Thomeer RTWM, Vanneste JAL: The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psych 2002, 72:503\u2013506.","journal-title":"J Neurol Neurosurg Psych"},{"issue":"suppl","key":"8_CR15","first-page":"S38","volume":"11","author":"Z Li","year":"2001","unstructured":"Li Z, Naugle RI, Wood A, et al.: Intermittent lumbar drainage with functional testing in the diagnosis of normal-pressure hydrocephalus. Eur J Pediatr Surg 2001, 11(suppl):S38-S40.","journal-title":"Eur J Pediatr Surg"},{"key":"8_CR16","first-page":"191","volume":"87","author":"N Giladi","year":"2001","unstructured":"Giladi N: Freezing of gait: clinical overview. Adv Neurol 2001, 87:191\u2013197. This is a very good discussion of pathology and treatment of freezing.","journal-title":"Adv Neurol"},{"key":"8_CR17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ptj\/80.6.578","volume":"80","author":"ME Morris","year":"2000","unstructured":"Morris ME: Movement disorders in people with Parkinson\u2019s disease: a model for physical therapy. Phys Ther 2000, 80:579\u2013597.","journal-title":"Phys Ther"},{"key":"8_CR18","first-page":"243","volume":"87","author":"S Mesure","year":"2001","unstructured":"Mesure S, Darmon A, Blin O: Imbalance of attentional and sensory inputs on gait. Adv Neurol 2001, 87:243\u2013250.","journal-title":"Adv Neurol"},{"key":"8_CR19","first-page":"255","volume":"87","author":"O Rascol","year":"2001","unstructured":"Rascol O, Fabre N, Brefel-Courbon C, Montastrue J-L: The pharmacologic treatment of gait ignition failure. Adv Neurol 2001, 87:255\u2013264.","journal-title":"Adv Neurol"},{"issue":"suppl","key":"8_CR20","first-page":"32","volume":"72","author":"R Gregory","year":"2002","unstructured":"Gregory R: Surgery for movement disorders. J Neurol Neurosurg Psychiatry 2002, 72(suppl):32\u201336. This is a good overview of available surgical options for movement disorders.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8_CR21","first-page":"289","volume":"87","author":"F Valldeoriola","year":"2001","unstructured":"Valldeoriola F, Molinuevo JL, Valls-Sole J: Bilateral subthalamic stimulation and parkinsonian gait. Adv Neurol 2001, 87:289\u2013299.","journal-title":"Adv Neurol"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/WNL.57.1.144","volume":"57","author":"H Stolze","year":"2001","unstructured":"Stolze H, Klebe S, Poepping M, et al.: Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait. Neurology 2001, 57:144\u2013146.","journal-title":"Neurology"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1212\/WNL.58.3.469","volume":"58","author":"R Figueras-Mendez","year":"2002","unstructured":"Figueras-Mendez R, Regidor I: Further supporting evidence of beneficial subthalamic stimulation in Parkinson\u2019s patients. Neurology 2002, 58:469\u2013470.","journal-title":"Neurology"},{"key":"8_CR24","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1212\/WNL.55.12.1921","volume":"55","author":"V Fraix","year":"2000","unstructured":"Fraix V, Pollak P: Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson\u2019s disease. Neurology 2000, 55:1921\u20131923.","journal-title":"Neurology"},{"key":"8_CR25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/WNL.58.3.396","volume":"58","author":"FJG Vingerhoets","year":"2002","unstructured":"Vingerhoets FJG: Subthalamic DBS replaces levodopa in Parkinson\u2019s disease. Neurology 2002, 58:396\u2013401.","journal-title":"Neurology"},{"key":"8_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0003-9993(99)90308-8","volume":"80","author":"NC Reynolds","year":"1999","unstructured":"Reynolds NC: Analysis of gait abnormalities in Huntington\u2019s disease. Arch Phys Med Rehabil 1999, 80:59\u201365.","journal-title":"Arch Phys Med Rehabil"},{"key":"8_CR27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00004714-200104000-00023","volume":"21","author":"G Bogelman","year":"2001","unstructured":"Bogelman G: Olanzapine and Huntington\u2019s disease. J Clin Psychopharmacol 2001, 21:245\u2013246.","journal-title":"J Clin Psychopharmacol"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1468-1331.2002.0354e.x","volume":"9","author":"AK Erdemoglu","year":"2002","unstructured":"Erdemoglu AK, Boratav C: Risperidone in chorea and psychosis of Huntington\u2019s disease. Eur J Neurol 2002, 9:182\u2013184.","journal-title":"Eur J Neurol"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jnnp.63.1.35","volume":"63","author":"JPP Vught","year":"1997","unstructured":"Vught JPP: Clozapine versus placebo in Huntington\u2019s disease: a double blind randomized comparative study. J Neurol Neurosurg Psychiatry 1997, 63:35\u201339.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8_CR30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1468-1331.2002.0354f.x","volume":"9","author":"RM Bonelli","year":"2002","unstructured":"Bonelli RM: Riluzole and olanzapine in Huntington\u2019s disease. Eur J Neurol 2002, 9:183\u2013184.","journal-title":"Eur J Neurol"},{"key":"8_CR31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00001756-200201210-00011","volume":"13","author":"KS Vaddadi","year":"2002","unstructured":"Vaddadi KS: A randomized, placebo-controlled, double blind study of treatment of Huntington\u2019s disease with unsaturated fatty acids. Neuroreport 2002, 13:29\u201333.","journal-title":"Neuroreport"},{"key":"8_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00001756-200201210-00029","volume":"13","author":"BK Puri","year":"2002","unstructured":"Puri BK: MRI and neuropsychological improvement in Huntington\u2019s disease following ethyl-EPA treatment. Neuroreport 2002, 13:123\u2013126.","journal-title":"Neuroreport"},{"key":"8_CR33","doi-asserted-by":"crossref","first-page":"A21","DOI":"10.1097\/00001756-200202110-00001","volume":"13:2","author":"A Rosser","year":"2002","unstructured":"Rosser A, Dunnett S. New drugs for Huntington\u2019s disease. Neuroreport 2002, 13:2:A21-A22.","journal-title":"Neuroreport"},{"key":"8_CR34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.58.5.687","volume":"58","author":"RA Hauser","year":"2002","unstructured":"Hauser RA: Bilateral human fetal striatal transplantation in Huntington\u2019s disease. Neurology 2002, 58:687\u2013695.","journal-title":"Neurology"},{"key":"8_CR35","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jnnp.66.3.278","volume":"66","author":"PD Thompson","year":"1999","unstructured":"Thompson PD: Orthostatic tremor. J Neurol Neurosurg Psych 1999, 66:278\u2013279.","journal-title":"J Neurol Neurosurg Psych"},{"key":"8_CR36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/jnnp.66.3.284","volume":"66","author":"B Boroojerdi","year":"1999","unstructured":"Boroojerdi B: Evidence for a non-orthostatic origin of orthostatic tremor. J Neurol Neurosrg Psych 1999, 66:284\u2013288. This paper gives evidence for a central oscillator mechanism in orthostatic tremor.","journal-title":"J Neurol Neurosrg Psych"},{"key":"8_CR37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/bmj.310.6973.143","volume":"310","author":"TC Britton","year":"1995","unstructured":"Britton TC, Thompson PD: Primary orthostatic tremor. BMJ 1995, 310:143\u2013144.","journal-title":"BMJ"},{"key":"8_CR38","first-page":"1565","volume":"59","author":"PD Charles","year":"1999","unstructured":"Charles PD: Classification of tremor and update on treatment. Am Fam Physician 1999, 59:1565\u20131572.","journal-title":"Am Fam Physician"},{"key":"8_CR39","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archneur.57.10.1519","volume":"57","author":"MF Finkel","year":"2000","unstructured":"Finkel MF: Pramipexole is a possible effective treatment for primary orthostatic tremor (shaky leg syndrome). Arch Neurol 2000, 57:1519\u20131520.","journal-title":"Arch Neurol"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp.66.5.681","volume":"66","author":"AJ Wills","year":"1999","unstructured":"Wills AJ: Levodopa may improve orthostatic tremor; case report and trial of treatment. J Neurol Neuosurg Psychiatry 1999, 66:681\u2013684.","journal-title":"J Neurol Neuosurg Psychiatry"},{"key":"8_CR41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0025-6196(11)63006-1","volume":"71","author":"JN Caviness","year":"1996","unstructured":"Caviness JN: Myoclonus. Mayo Clin Proc 1996, 71:679\u2013688.","journal-title":"Mayo Clin Proc"},{"issue":"suppl","key":"8_CR42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870150702","volume":"15","author":"S Frucht","year":"2000","unstructured":"Frucht S, Fahn S: The clinical spectrum of posthypoxic myoclonus. Mov Disord 2000, 15(suppl):2\u20137.","journal-title":"Mov Disord"},{"issue":"suppl","key":"8_CR43","first-page":"49","volume":"32","author":"P Genton","year":"1999","unstructured":"Genton P: Piracetam in the treatment of cortical myoclonus. Pharmacopsychiatry 1999, 32(suppl):49\u201353.","journal-title":"Pharmacopsychiatry"},{"key":"8_CR44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mds.870110615","volume":"11","author":"A Ikeda","year":"1996","unstructured":"Ikeda A: Clinical trial of piracetam in patients with myoclonus: Nationwide multi-institution study in Japan. Mov Disord 1996, 11:691\u2013700.","journal-title":"Mov Disord"},{"key":"8_CR45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1212\/WNL.56.3.411","volume":"56","author":"GL Krauss","year":"2001","unstructured":"Krauss GL: Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam. Neurology 2001, 56:411\u2013412.","journal-title":"Neurology"},{"key":"8_CR46","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1136\/bmj.318.7200.1710","volume":"318","author":"M Hadjivassiliou","year":"1999","unstructured":"Hadjivassiliou M: Gluten sensitivity: a many headed hydra. BMJ 1999, 318:1710\u20131711.","journal-title":"BMJ"},{"key":"8_CR47","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/brain\/124.5.1013","volume":"124","author":"K Burk","year":"2001","unstructured":"Burk K: Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 2001, 124:1013\u20131019.","journal-title":"Brain"},{"key":"8_CR48","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.108","volume":"49","author":"O Khalafalla","year":"2001","unstructured":"Khalafalla O: Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 2001, 49:540\u2013543.","journal-title":"Ann Neurol"},{"key":"8_CR49","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ana.1281","volume":"50","author":"K Burk","year":"2001","unstructured":"Burk K: Effectiveness of intravenous immunoglobulin therapy in cerebellar ataxia associated with gluten sensitivity. Ann Neurol 2001, 50:827\u2013828.","journal-title":"Ann Neurol"},{"key":"8_CR50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0025-6196(11)64217-1","volume":"75","author":"GH Virgilio","year":"2000","unstructured":"Virgilio GH: Hereditary ataxias. Mayo Clin Proc 2000, 75:475\u2013490.","journal-title":"Mayo Clin Proc"},{"key":"8_CR51","unstructured":"A comprehensive review of movement disorders for the clinical practitioner. Presented at Columbia University College of Physicians and Surgeons; New York, NY; August 2002."},{"key":"8_CR52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0306-9877(98)90032-9","volume":"51","author":"MI Botez","year":"1998","unstructured":"Botez MI: The treatment of spinocerebellar ataxias: facts and hypotheses. Med Hypotheses 1998, 51:381\u2013384. Article describes the current theories regarding the role of serotonin in cerebellar ataxias.","journal-title":"Med Hypotheses"},{"issue":"suppl","key":"8_CR53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1468-1331.2002.0090s1023.x","volume":"9","author":"K-H Mauritz","year":"2002","unstructured":"Mauritz K-H: Gait training in hemiplegia. Eur J Neurol 2002, 9(suppl):23\u201329.","journal-title":"Eur J Neurol"},{"key":"8_CR54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/jnnp.72.1.53","volume":"72","author":"MM Lanotte","year":"2002","unstructured":"Lanotte MM: Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 2002, 72:53\u201358.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8_CR55","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","volume":"59","author":"CW Shults","year":"2002","unstructured":"Shults CW: Effects of coenzyme Q10 in early Parkinson\u2019s disease. Arch Neurol 2002, 59:1541\u20131550.","journal-title":"Arch Neurol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-003-0008-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-003-0008-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-003-0008-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:30:11Z","timestamp":1587580211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-003-0008-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s11940-003-0008-x","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}